Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus.
Oncotarget. 2016 Mar 1;7(9):10547-56. doi: 10.18632/oncotarget.7234.
Oncotarget. 2016.
PMID: 26859683
Free PMC article.